homemarket Newsstocks NewsRemain focused on companies with exposure to Indian markets, says India Infoline
Remain focused on companies with exposure to Indian markets, says India Infoline
watch full video of Abhishek Sharma with CNBC-TV18.
India Infoline, a financial service firm issued a report on pharmaceutical companies, specifically analyzing US business margins.
The report suggested that there has been a 1,200 bps kind of a margin erosion for Indian companies which are serving the US generic markets as a whole. Out of that, half of the margin erosion has come because of the price pressure and the other half has come because of the increased R&D activities.
"We essentially remain focused on companies which have a higher share of EBITDA coming out of India and other markets as compared to US where we still see challenges going forward in terms of pricing pressure continuing", said Abhishek Sharma, Vice President and Pharma Analyst at IIFL.
"On that parameter, we would essentially like companies like Torrent and Alkem Labs, which still continue to derive a lion share of their EBITDA from this market", he further added.
Sharma also stated that Biocon has efficiently played out in the last one to one and a half years.
First Published: Mar 19, 2018 10:12 AM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
